Abstract:
The present invention provides novel panels of molecular targets that regulate erythropoiesis. The novel panels of the invention may be used, for example, in therapeutic intervention, therapeutic agent screening, and in diagnostic methods for diseases and/or disorders of erythropoiesis.
Abstract:
Compounds which exhibit anti-adhesive properties are described. The compounds may be monomers or polymers. Methods for treating receptor mediated diseases are provided using compounds of the invention. Further methods are provided for crop protection, medical devices and anti-fouling.
Abstract:
This invention includes methods for analyzing single-stranded nucleic acid sequences, either RNA sequences or DNA sequences (ssDNA) utilizing dyes that fluoresce when associated with double strands, so-called DNA binding dyes or dsDNA-dyes. Methods according to this invention utilize a dsDNA-dye in combination with one or more hybridization probes that hybridize to a target nucleic acid sequence and that are labeled with a non-fluorescent quencher moiety, for example, a Black Hole quencher.
Abstract:
Featured herein are engineered human cells, which express an exogenous extracellular binding partner to an apoptotic or necrotic cellular antigen and at least one exogenous intracellular signaling domain. These genetically-engineered cells can function as immune modulators that specifically recognize dying cells or tissues and upon binding, secrete Th1 cytokines including IL-2 and IFN-gamma, thereby achieving a localized pro-inflammatory response at the site of tumor tissues.
Abstract:
The present invention is directed to methods of treating or preventing RNA polymerase dependent viral disorders using JAK2 kinase inhibitors or agents that inhibit HEXIM1 tyrosine phosphorylation. In a particular aspect the present invention is directed to the treatment of prevention of HIV infection in a subject by administration of JAK2 kinase inhibitors or agents that inhibit HEXIM1 tyrosine phosphorylation.
Abstract:
The invention provides natural IgM antibodies that may be used to induce inflammatory diseases or disorders such as ischemia-reperfusion injury to create animal models of such inflammatory diseases or disorders.
Abstract:
Compositions and methods are disclosed that relate to a biopolymer medium for growing plants. In certain embodiments, the biopolymer growth medium comprises or consists essentially of polylactic acid (PLA), polyhydroxyalkanoate (PHA) or a mixture of them. Another aspect of the invention relates to a method of producing a biopolymer growth medium.
Abstract:
The present invention is directed to methods and compositions for manipulating electroprocessed scaffold material properties using cross-linking and fiber tertiary structure. The methods and compositions can be combined with methods and compositions directed to formation and use of electroprocessed materials, such as collagen and fibrin.